Skip to main content

Neuropathic Bone Metastases

  • Chapter
  • First Online:
Bone Metastases

Part of the book series: Cancer Metastasis - Biology and Treatment ((CMBT,volume 21))

  • 1746 Accesses

Abstract

Neuropathic pain is defined as pain arising as a direct consequence of a lesion or disease affecting the somatosensory part of the nervous system. Several validated instruments exist for its diagnosis and for assessment of response to treatment. Neuropathic pain is common in cancer patients, and may occur as a consequence of bone or soft-tissue metastases in the vicinity of nerve(s), although there is debate about the mechanism. There are limited data on the use of radiotherapy to palliate neuropathic pain of malignant origin in general, and due to bone metastases in particular. One randomized trial comparing a single 8 Gy with 20 Gy in five fractions for neuropathic bone pain (Trans Tasman Radiation Oncology Group, TROG 96.05) found no statistically significant difference in outcomes between the arms, and response rates were of similar magnitude to those observed for localized bone pain. However, further research will be required to determine whether higher doses are more effective.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Treede RD, Jensen TS, Campbell JN et al (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630–1635

    Article  PubMed  CAS  Google Scholar 

  2. Roos DE, Turner SL, O’Brien PC et al (2005) Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 75:54–63

    Article  PubMed  Google Scholar 

  3. Bennett MI, Rayment C, Hjermstad M et al (2012) Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain 153:359–365

    Article  PubMed  Google Scholar 

  4. Kerba M, Wu JSY, Duan Q et al (2010) Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy. J Clin Oncol 28:4892–4897

    Article  PubMed  Google Scholar 

  5. Manas A, Monroy JL, Ramos AA et al (2011) Prevalence of neuropathic pain in radiotherapy oncology units. Int J Radiat Oncol Biol Phys 81:511–520

    Article  PubMed  Google Scholar 

  6. Bone Pain Trial Working Party (1999) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomized comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 52:111–121

    Article  Google Scholar 

  7. Price P, Hoskin PJ, Easton D et al (1986) Prospective randomized trial of single and multi-fraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 6:247–255

    Article  PubMed  CAS  Google Scholar 

  8. Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138

    PubMed  CAS  Google Scholar 

  9. Bennett MI, Smith BH, Torrance N et al (2005) The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 6:149–158

    PubMed  Google Scholar 

  10. Galer BS, Jensen MP (1997) Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology 48:332–338

    Article  PubMed  CAS  Google Scholar 

  11. Bouhassira D, Attal N, Fermanian J et al (2004) Development and validation of the neuropathic pain symptom inventory. Pain 108:248–257

    Article  PubMed  Google Scholar 

  12. Roos DE (2000) Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review. Radiother Oncol 56:315–322

    Article  PubMed  CAS  Google Scholar 

  13. Fairchild A, Barnes E, Ghosh S et al (2009) International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys 75:1501–1510

    Article  PubMed  Google Scholar 

  14. Merskey H, Bogduk N (1994) Classification of chronic pain. IASP Press, Seattle

    Google Scholar 

  15. Roos DE, Davis S, O’Brien P et al (2000) Eligibility audits for the neuropathic bone pain trial (TROG 96.05). Australas Radiol 44:303–307

    Article  PubMed  CAS  Google Scholar 

  16. Roos DE, Davis SR, Turner SL et al (2003) Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 67:207–212

    Article  PubMed  Google Scholar 

  17. Dennis K, Chow E, Roos D et al (2011) Should bone metastases causing neuropathic pain be treated with single dose radiotherapy? Editorial. Clin Oncol (R Coll Radiol) 23:482–484

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Roos .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Roos, D. (2014). Neuropathic Bone Metastases. In: Vassiliou, V., Chow, E., Kardamakis, D. (eds) Bone Metastases. Cancer Metastasis - Biology and Treatment, vol 21. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7569-5_15

Download citation

Publish with us

Policies and ethics